Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K/Akt/eNOS pathway
Autor: | Dimeng Wang, Huihui Bao, Yang Zhang, Xiaoshu Cheng, Kefei Wan, Hanyue Deng, Qinghua Wu, Zongyu Xu, Xiaohong Hu, Biming Zhan, Hong Wang, Xiao Huang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine Homocysteine Myocardial Infarction Pharmacology Ventricular Function Left Mice Phosphatidylinositol 3-Kinases chemistry.chemical_compound 0302 clinical medicine Enos Coronary microvascular dysfunction Myocardial infarction Hypoxia Nicorandil Cells Cultured Tube formation biology General Medicine PI3K/Akt/eNOS pathway Platelet Endothelial Cell Adhesion Molecule-1 Nitric oxide synthase NG-Nitroarginine Methyl Ester 030220 oncology & carcinogenesis cardiovascular system Plant Lectins medicine.drug Nitric Oxide Synthase Type III Cell Survival Morpholines Hyperhomocysteinemia RM1-950 03 medical and health sciences medicine Animals Humans Protein kinase B PI3K/AKT/mTOR pathway business.industry Microcirculation Endothelial Cells medicine.disease biology.organism_classification 030104 developmental biology chemistry Chromones biology.protein Therapeutics. Pharmacology business Proto-Oncogene Proteins c-akt |
Zdroj: | Biomedicine & Pharmacotherapy, Vol 127, Iss, Pp 110121-(2020) |
ISSN: | 0753-3322 |
Popis: | Objective Nicorandil exerts a protective effect against coronary microvascular dysfunction in acute myocardial infarction (AMI) patients. However, the mechanism and effect of nicorandil in hyperhomocysteinemia (HHcy) AMI patients remain unclear. Methods C57/BL6 mice with mild to moderate HHcy and human coronary artery endothelial cells (HCAECs) cotreated with HHcy (1 mmol/L) for 24 h and hypoxia for 6 h were selected as models. Small animal ultrasound detection was used to compare cardiac function. CD31 immunofluorescence staining and tomato lectin staining were used to assess the number of microcirculation changes in vivo. MTT, tube formation and western blotting assays were used to evaluate the effect of nicorandil on HCAECs and the PI3K/Akt/eNOS pathway. Results The results showed that nicorandil improved cell viability and p-PI3K/PI3K, p-Akt/Akt, and p-eNOS/eNOS expression in the vitro HHcy and hypoxia models. The beneficial effects of nicorandil on HCAECs could be inhibited by the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 and the nitric oxide synthase (NOS) inhibitor L-NAME. In vivo, nicorandil improved the left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) in the post-HHcy + MI model, and the levels of CD31 and tomato lectin expression were higher in the nicorandil treatment group. The effectiveness of nicorandil was inhibited in the PI3K and L-NAME groups. Conclusion The results suggest that nicorandil improves Hcy-induced coronary microvascular dysfunction through the PI3K/Akt/eNOS signalling pathway. |
Databáze: | OpenAIRE |
Externí odkaz: |